Federal Register Final rule: FDA is amending its postmarketing safety reporting regulations for human drug and biological products to require that persons subject to mandatory reporting requirements submit safety reports in an electronic format that FDA can process, review, and archive. The rule is effective 6/10/15. To view this final rule, click here.
